Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05051124 · ClinicalTrials.gov registry record · NA
Peers and Technology for Adherence, Access, Accountability, and Analytics
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
NCT05051124 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 101 participants.
The verdict
NCT05051124, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
Study Summary
The overall objective of this project is to utilize the PRECEDE-PROCEED framework to conduct transdisciplinary, translational implementation research focused on improving medication adherence for hypertension control. The central hypothesis is that peer delivery of medications integrated with HIT (PT4A) will be effective in improving hypertension medication adherence, contributing to improved blood pressure among patients with uncontrolled hypertension in western Kenya. This study record will focus on Sub-Aim 2.2: a pilot of the intervention and a survey questionnaire with patients, peers, and clinical staff to evaluate feasibility. The investigators will evaluate impact on systolic blood pressure, medication adherence, and fidelity of implementation. The investigators will also create a retrospective comparator (control) group of CDM patients, through querying AMRS, matched by sex, age, location and initial blood pressure level. The investigators will then use their recorded blood pressure over a comparable period of up to 1 year and to allow for comparison to the blood pressure changes observed in the patients enrolled in the PT4A program to help understand the magnitude and variance of the intervention effects.
Interventions
- BEHAVIORAL Peer Delivery of Medications
- BEHAVIORAL Health Information Technology (HIT) Platform
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2022-04-19 |
| Est. Completion | 2024-01-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05051124
The ClinicalTrials.gov registry entry for NCT05051124 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Peer Delivery of Medications is the first listed.
NCT05051124 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05051124 about?
NCT05051124 is a clinical study titled "Peers and Technology for Adherence, Access, Accountability, and Analytics". The overall objective of this project is to utilize the PRECEDE-PROCEED framework to conduct transdisciplinary, translational implementation research focused on improving medication adherence for hypertension control. The central hypothesis is that peer delivery of medications integrated with HIT (P...
What is the current status of trial NCT05051124?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2022-04-19. Estimated completion is 2024-01-25.
What interventions are being tested in trial NCT05051124?
The interventions under investigation include: Peer Delivery of Medications (BEHAVIORAL), Health Information Technology (HIT) Platform (BEHAVIORAL).
Who is sponsoring clinical trial NCT05051124?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.